Negative myoclonus is a sudden, brief loss of muscle activity rather than a sudden muscle contraction. Where most people think of a “jerk” or twitch when they hear the word myoclonus, the negative form is essentially the opposite: muscles that should be holding steady abruptly go silent, sometimes causing a limb to drop or the whole body to buckle. The phenomenon arises from the brain commanding a pause in ongoing muscle tone, and it shows up in a surprisingly wide range of neurological and metabolic conditions.
Positive Versus Negative Myoclonus
Myoclonus in general refers to sudden, shock-like involuntary movements originating in the central nervous system. The “positive” kind is what most people picture: a quick jerk caused by muscles firing when they should not be. Positive myoclonus is common and mostly harmless in everyday life. Nearly everyone has experienced a hypnic jerk while falling asleep, or a hiccup, both of which are forms of positive myoclonus.1Electroencephalography and Clinical Neurophysiology. Neurophysiology of positive and negative myoclonus
Negative myoclonus flips the script. Instead of an unwanted contraction, there is an unwanted silence. On an electromyography recording, it appears as a brief gap, lasting less than 500 milliseconds, in what should be continuous muscle activity. That gap is not preceded by any spike in contraction, which is what distinguishes it from a jerk followed by relaxation.2PubMed. Negative myoclonus induced by cortical electrical stimulation in epileptic patients Both positive and negative forms often coexist in the same person, which can make the negative variety easy to overlook. A clinician watching for jerks may not notice the moments when muscles simply switch off.3Electroencephalography and Clinical Neurophysiology. Neurophysiology of positive and negative myoclonus
What Happens in the Brain
The fact that muscles can be actively inhibited by the brain, not just actively contracted, is central to understanding negative myoclonus. Research using electrodes placed directly on the brain surface in epilepsy patients has traced the signal to the postcentral cortex, the strip of brain tissue just behind the primary motor area. When abnormal electrical spikes arise in this region, they appear to shut down the tonic activity of motor neurons on the opposite side of the body. The larger the area of cortex involved in the spike, the longer the muscle silence lasts.4PubMed. Epileptic negative myoclonus: Subdural EEG recordings indicate a postcentral generator
The story is not limited to the postcentral area, though. Neuroimaging and direct brain stimulation studies have implicated a broader network, including the premotor cortex, the primary motor cortex, and the supplementary motor area. Subcortical structures deep in the brain can also play a role.5PubMed. Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management The key point is that negative myoclonus is not simply a failure of the motor system. It is an active inhibitory command, generated by specific brain circuits, that briefly silences muscles in mid-contraction.
The latency from brain spike to muscle silence is extremely short, on the order of 20 to 30 milliseconds, which confirms a fast, direct cortical pathway rather than a slow, reflexive loop.6PubMed. Epileptic negative myoclonus: Subdural EEG recordings indicate a postcentral generator This speed also explains why the lapses feel so abrupt and are nearly impossible to anticipate or resist.
Epileptic Negative Myoclonus in Children
One of the best-studied settings for negative myoclonus is childhood epilepsy, particularly a condition called benign epilepsy with centrotemporal spikes, commonly known as rolandic epilepsy. This is one of the most common epilepsy syndromes in school-age children, and it usually resolves on its own by adolescence. In some of these children, the presenting symptom is not a convulsion but rather sudden, unexplained falls. The child’s arm drops, or a leg gives way, or they pitch forward, all because the muscles briefly switch off in response to an epileptic discharge.7PubMed Central. Epileptic negative myoclonus as the presenting seizure type in rolandic epilepsy
Epileptic negative myoclonus is considered a rare seizure type overall, but it has been documented across a range of epilepsy syndromes beyond rolandic epilepsy, including progressive myoclonic epilepsy, symptomatic partial epilepsy caused by structural brain abnormalities, and cryptogenic epilepsies where the cause remains unknown.8PubMed. Epileptic negative myoclonus in herpes simplex virus encephalitis Video-EEG monitoring in affected children typically shows the muscle silence originating from spikes in the central and parietal brain regions on the side opposite the affected limb.9PubMed Central. Epileptic Negative Myoclonus as the First and Only Symptom in a Challenging Diagnosis of Benign Epilepsy With Centrotemporal Spikes
What makes this tricky for families and clinicians is that the falls look like clumsiness rather than seizures. A child who keeps dropping things or stumbling may be sent to an orthopedist or a physical therapist long before anyone thinks to order an EEG. Recognizing negative myoclonus as a seizure type, rather than a motor coordination problem, is the diagnostic breakthrough that changes how the child is treated.
Asterixis, the Most Common Form You Have Probably Never Heard Of
If you have ever seen a person with advanced liver disease hold their hands outstretched and watched their wrists flap downward in an irregular rhythm, you have witnessed asterixis. Asterixis is a form of negative myoclonus: those flapping movements are not caused by the muscles contracting but by the muscles briefly stopping their contraction, allowing the wrist to drop before the muscles resume and pull it back up.10PubMed Central. Flapping Tremor: Unraveling Asterixis-A Narrative Review
The name “flapping tremor” is actually a misnomer, because it is not a tremor at all. Tremors involve rhythmic oscillation driven by alternating muscle contractions. Asterixis is arrhythmic and driven by lapses, not contractions. It is most closely associated with hepatic encephalopathy, the brain fog and motor dysfunction that occur when a failing liver cannot clear toxins from the blood, but it also shows up in kidney failure, severe respiratory failure, certain cerebrovascular diseases, and as a side effect of drugs such as valproic acid, carbamazepine, and phenytoin.11PubMed Central. Flapping Tremor: Unraveling Asterixis-A Narrative Review
An interesting wrinkle is that asterixis is often asymptomatic in the sense that patients do not spontaneously report it. They may not notice the brief lapses in posture unless someone asks them to hold their hands out. This subtlety means it can serve as a useful bedside screening test for metabolic encephalopathy: if a patient’s wrists flap when extended, something toxic is likely building up in the bloodstream.
Structural Brain Lesions and Strokes
Negative myoclonus does not always come from epilepsy or metabolic toxins. Structural damage to specific brain regions can produce it as well. Strokes affecting the thalamus, particularly the ventrolateral and ventroposterior nuclei, are a recognized cause. These cases tend to be unilateral, affecting the side of the body opposite the damaged thalamus, and they account for a small fraction, roughly 2%, of post-stroke movement disorders.12Tremor and Other Hyperkinetic Movements. Negative Myoclonus Secondary to Thalamic Infarction: Case Report
Beyond the thalamus, lesions in the frontal lobe, the internal capsule, the precentral cortex, the midbrain, or even the cerebellum have all been linked to negative myoclonus in case reports.13Tremor and Other Hyperkinetic Movements. Negative Myoclonus Secondary to Thalamic Infarction: Case Report This geographic spread reinforces the idea that multiple brain circuits can, when disrupted, produce the same result: an involuntary pause in muscle contraction. The common thread appears to be interference with the pathways that maintain steady muscle tone.
When Antiepileptic Drugs Make Things Worse
One of the more counterintuitive aspects of negative myoclonus is that certain drugs prescribed to treat epilepsy can actually trigger or worsen it. Carbamazepine, a widely used medication for focal seizures, has been linked to a clear aggravation pattern in some children with rolandic epilepsy. Instead of controlling their seizures, carbamazepine can bring on negative myoclonus, atypical absences, and drop attacks. In the worst cases, it pushes the EEG pattern toward near-continuous abnormal electrical activity during sleep.14PubMed. When antiepileptic drugs aggravate epilepsy
Lamotrigine has produced a similar paradoxical reaction. In at least one well-documented case involving a child with rolandic epilepsy, lamotrigine treatment led to seizure deterioration, the emergence of new seizure types including negative myoclonus, and temporary cognitive impairment.15PubMed. Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy Gabapentin and pregabalin have also been implicated as drugs that can induce negative myoclonus, particularly in patients with compromised kidney function who may accumulate higher blood levels of these medications.16Journal of the Neurological Sciences. Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review
The practical message here matters: if someone with epilepsy, especially a child with rolandic epilepsy, starts falling more often or develops new types of episodes after starting or increasing a medication, drug-induced negative myoclonus should be on the differential. Recognizing this pattern can prevent months of escalating doses of a medication that is making the problem worse.
How Negative Myoclonus Is Detected
Catching negative myoclonus can be genuinely difficult because, by definition, nothing visibly “happens” in the way a convulsive jerk does. The gold standard for identifying it involves simultaneous video recording and EEG monitoring, often combined with surface electromyography placed over the affected muscles. What clinicians look for is a time-locked relationship: an epileptic spike or sharp wave on the EEG, followed within milliseconds by a silent period on the muscle recording, without any preceding muscle contraction.17PubMed. Epileptic negative myoclonus in herpes simplex virus encephalitis
In patients who have both positive and negative myoclonus, the negative variety is especially easy to miss because the preceding jerks tend to draw all the attention. A neurophysiological study in patients with progressive myoclonus ataxia found that careful electrophysiological testing could pick up negative myoclonus that was invisible on standard clinical examination, masked by the more obvious positive jerks happening alongside it.18PubMed. Negative Myoclonus: Neurophysiological Study and Clinical Impact in Progressive Myoclonus Ataxia This finding has clinical weight, because the presence of negative myoclonus may alter treatment decisions and influence the functional prognosis.
More recently, researchers have explored wearable sensors for long-term home monitoring. A study using surface EMG worn during daily activities developed an algorithm that detects the silent periods characteristic of negative myoclonus, categorizing them as short (50 to 69 milliseconds), intermediate (70 to 100 milliseconds), or long (101 to 500 milliseconds). The algorithm’s output correlated strongly with physician-rated scales for both negative myoclonus severity and overall functional status, suggesting that continuous monitoring outside the hospital could one day help clinicians track this elusive phenomenon between clinic visits.19Clinical Neurophysiology. Detecting negative myoclonus during long-term home measurements using wearables
Treatment Approaches
How negative myoclonus is treated depends entirely on what is causing it. In epileptic forms, particularly in children with rolandic epilepsy, valproate and levetiracetam have both shown effectiveness in controlling the episodes.20PubMed Central. Epileptic Negative Myoclonus as the First and Only Symptom in a Challenging Diagnosis of Benign Epilepsy With Centrotemporal Spikes Ethosuximide, a drug more commonly associated with treating absence seizures, has also proven effective. In one study, epileptic negative myoclonus disappeared within 15 to 30 days of starting ethosuximide, leading the authors to suggest it should be considered a first-line option for this specific seizure type.21PubMed. Ethosuximide is effective in the treatment of epileptic negative myoclonus in childhood partial epilepsy
When negative myoclonus is caused by a metabolic problem like hepatic encephalopathy, the treatment targets the underlying condition. Lowering ammonia levels, supporting liver or kidney function, or removing an offending drug can resolve asterixis without any direct neurological intervention. For drug-induced cases, reducing the dose or switching to a different medication is usually sufficient. The cases triggered by carbamazepine, lamotrigine, gabapentin, or pregabalin generally improve once the offending drug is identified and adjusted.
Structural causes, such as negative myoclonus following a thalamic stroke, are more complex. Some patients recover as the acute brain injury heals, while others may need long-term symptomatic management. The evidence base for treating post-stroke negative myoclonus specifically is thin, consisting largely of case reports rather than controlled trials.
Why Negative Myoclonus Matters More Than Its Rarity Suggests
Despite being considered uncommon, negative myoclonus punches above its weight in terms of real-world impact. A brief muscle lapse in a hand might cause someone to drop a cup. The same lapse in a leg can cause a fall. In children, unexplained falls can lead to injuries, social embarrassment, and misdiagnosis as developmental coordination disorder. In older adults with liver disease, asterixis can herald worsening encephalopathy before other symptoms become obvious.
The broader lesson of negative myoclonus is that the nervous system does not just create movement; it actively maintains stillness and posture through continuous effort. When that effort is disrupted, even for a fraction of a second, the consequences can be dramatic. Clinicians who are aware of negative myoclonus as a distinct entity are better positioned to recognize it in patients whose symptoms do not fit the typical seizure or tremor categories, and to avoid the treatment traps, like prescribing carbamazepine for a child whose rolandic epilepsy then spirals, that come from not recognizing it.
Progressive Neurological Conditions and Negative Myoclonus
Beyond childhood epilepsy and metabolic encephalopathy, negative myoclonus plays a clinically significant role in progressive neurological diseases, particularly the group of disorders known as progressive myoclonic epilepsies and progressive myoclonus ataxias. These are rare, often genetic conditions that worsen over time and involve a mix of seizures, movement problems, and sometimes cognitive decline. In these patients, negative myoclonus can be a major driver of disability even when positive myoclonus seems to be the more dramatic symptom.
Research focusing on progressive myoclonus ataxia has demonstrated that negative myoclonus contributes independently to loss of function. Patients who appear to be struggling mainly with jerks and coordination problems may actually be undermined as much by the brief lapses in muscle tone that cause stumbling, fumbling, and instability. Identifying this component through neurophysiological testing changes the clinical picture because it suggests a different therapeutic target.22PubMed. Negative Myoclonus: Neurophysiological Study and Clinical Impact in Progressive Myoclonus Ataxia Treating only the positive jerks and ignoring the silent gaps would leave a major source of impairment unaddressed.
The coexistence of positive and negative myoclonus in these conditions also complicates medication choices. A drug that reduces positive jerks might have no effect on, or even worsen, the negative component. This is part of why management of progressive myoclonic conditions remains challenging and highly individualized, often requiring combinations of medications and close neurophysiological follow-up to track which components of the movement disorder are responding to treatment.